Physicians’ Tastes For Pricier Implants Not Always Improving Patient Results, Hospital Group Says
This article was originally published in The Gray Sheet
Executive Summary
UHC, an alliance of nonprofit academic centers, released a white paper finding that higher-priced physician preferences for orthopedic implants, coronary and peripheral stents and heart valves are increasing hospitals’ supply costs, but not necessarily improving patients’ outcomes.
You may also be interested in...
AdvaMed: Devices Not The Cause Of Health Care Inflation
The price of implantable devices declined between 2007 and 2011, according to an AdvaMed-sponsored study. Industry officials touted the finding at the trade group’s annual medtech conference in Washington, D.C.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.